Literature DB >> 11345439

A selection system for identifying accessible sites in target RNAs.

W H Pan1, H F Devlin, C Kelley, H C Isom, G A Clawson.   

Abstract

Although ribozymes offer tremendous potential for posttranscriptionally controlling expression of targeted genes, their utility is often limited by the accessibility of the targeted regions within the RNA transcripts. Here we describe a method that identifies RNA regions that are accessible to oligonucleotides. Based on this selection protocol, we show that construction of hammerhead ribozymes targeted to the identified regions results in catalytic activities that are consistently and substantially greater than those of ribozymes designed on the basis of computer modeling. Identification of accessible sites should also be widely applicable to design of antisense oligonucleotides and DNAzymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11345439      PMCID: PMC1370114          DOI: 10.1017/s1355838201001595

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  32 in total

1.  Growth inhibition by a triple ribozyme targeted to repetitive B2 transcripts.

Authors:  T M Crone; S L Schalles; C M Benedict; W Pan; L Ren; S E Loy; H Isom; G A Clawson
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

2.  Nucleic Acid Selection and the Challenge of Combinatorial Chemistry.

Authors:  Scott E. Osborne; Andrew D. Ellington
Journal:  Chem Rev       Date:  1997-04-01       Impact factor: 60.622

3.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

4.  Using reliability information to annotate RNA secondary structures.

Authors:  M Zuker; A B Jacobson
Journal:  RNA       Date:  1998-06       Impact factor: 4.942

5.  Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes.

Authors:  P Hendry; M McCall
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

6.  Isolation of virus-neutralizing RNAs from a large pool of random sequences.

Authors:  W Pan; R C Craven; Q Qiu; C B Wilson; J W Wills; S Golovine; J F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

7.  In situ demonstration of inhibitory effects of hammerhead ribozymes that are targeted to the hepatitis Bx sequence in cultured cells.

Authors:  M Passman; M Weinberg; M Kew; P Arbuthnot
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

8.  Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.

Authors:  T Suzuki; B Anderegg; T Ohkawa; A Irie; O Engebraaten; M Halks-Miller; P S Holm; D T Curiel; M Kashani-Sabet; K J Scanlon
Journal:  Gene Ther       Date:  2000-02       Impact factor: 5.250

Review 9.  The therapeutic potential of ribozymes.

Authors:  H A James; I Gibson
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

10.  Triple ribozyme-mediated down-regulation of the retinoblastoma gene.

Authors:  C M Benedict; W Pan; S E Loy; G A Clawson
Journal:  Carcinogenesis       Date:  1998-07       Impact factor: 4.944

View more
  8 in total

1.  Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.

Authors:  Peter A C 't Hoen; Ruud Out; Jan N M Commandeur; Nico P E Vermeulen; F H D van Batenburg; Muthiah Manoharan; Theo J C van Berkel; Erik A L Biessen; Martin K Bijsterbosch
Journal:  RNA       Date:  2002-12       Impact factor: 4.942

Review 2.  Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; R Thomas Taggart; Mark C Butler; Tiffany A Kolniak
Journal:  Vision Res       Date:  2007-10-31       Impact factor: 1.886

3.  Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus.

Authors:  Lucien Junior Bergeron; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

4.  Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer.

Authors:  Qiang-Song Tong; Li-Duan Zheng; Fang-Min Chen; Fu-Qing Zeng; Liang Wang; Ji-Hua Dong; Gong-Cheng Lu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  MicroRNAs align with accessible sites in target mRNAs.

Authors:  Weihua Pan; Ping Xin; Gary A Clawson
Journal:  J Cell Biochem       Date:  2010-02-15       Impact factor: 4.429

6.  Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth.

Authors:  Jinming Yang; Wei-Hua Pan; Gary A Clawson; Ann Richmond
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

7.  Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; Tiffany A Kolniak; Lowell G Sheflin; R Thomas Taggart; Heba E Abdelmaksoud
Journal:  J Ophthalmol       Date:  2011-06-30       Impact factor: 1.909

Review 8.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.

Authors:  Scott K Silverman
Journal:  Nucleic Acids Res       Date:  2005-11-11       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.